Mesa Laboratories Inc. (NASDAQ:MLAB) Director H Stuart Campbell sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, September 16th. The shares were sold at an average price of $115.03, for a total transaction of $345,090.00. Following the transaction, the director now directly owns 67,930 shares of the company’s stock, valued at approximately $7,813,987.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Shares of Mesa Laboratories Inc. (NASDAQ:MLAB) opened at 121.48 on Thursday. The stock’s 50 day moving average is $114.50 and its 200-day moving average is $110.86. Mesa Laboratories Inc. has a 12-month low of $77.00 and a 12-month high of $131.88. The stock has a market cap of $445.22 million, a PE ratio of 44.35 and a beta of 0.66.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 15th. Investors of record on Wednesday, November 30th will be paid a dividend of $0.16 per share. The ex-dividend date is Monday, November 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.53%. Mesa Laboratories’s dividend payout ratio (DPR) is presently 23.97%.
Separately, Zacks Investment Research cut shares of Mesa Laboratories from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 10th.
About Mesa Laboratories
Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.
Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.